SIGLEC15 and bladder transitional cell carcinoma: In immune checkpoint analysis, three immune checkpoint genes (HAVCR2, PDCD1LG2, SIGLEC15) were significantly different between high and low-risk groups of BLCA and normal adjacent tissues.